The role of daratumumab in relapsed/refractory CD38 positive acute leukemias—case report on three cases with a literature review

Primary refractory or relapsed T-cell acute lymphoblastic leukemia (T-ALL) and mixed phenotype myeloid/T-cell acute leukemia have dismal prognoses. New treatment approaches, preferably targeting specific leukemic aberrations to overcome resistance, are urgently needed. The bright expression of the C...

Descripción completa

Detalles Bibliográficos
Autores principales: Prejzner, Witold, Piekoś, Oliwia, Bełdzińska, Karolina, Sadowska-Klasa, Alicja, Zarzycka, Ewa, Bieniaszewska, Maria, Lewandowski, Krzysztof, Zaucha, Jan Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628456/
https://www.ncbi.nlm.nih.gov/pubmed/37941558
http://dx.doi.org/10.3389/fonc.2023.1228481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628456/
https://www.ncbi.nlm.nih.gov/pubmed/37941558
http://dx.doi.org/10.3389/fonc.2023.1228481

Ejemplares similares